Barry H Greenberg. J Card Fail 2002
Times Cited: 8
Times Cited: 8
Times Cited
Times Co-cited
Similarity
Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.
Stephanie Greenstein, Kulsoom Ghias, Nancy L Krett, Steven T Rosen. Clin Cancer Res 2002
Stephanie Greenstein, Kulsoom Ghias, Nancy L Krett, Steven T Rosen. Clin Cancer Res 2002
25
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
M Packer, M R Bristow, J N Cohn, W S Colucci, M B Fowler, E M Gilbert, N H Shusterman. N Engl J Med 1996
M Packer, M R Bristow, J N Cohn, W S Colucci, M B Fowler, E M Gilbert, N H Shusterman. N Engl J Med 1996
25
Effect of carvedilol on survival in severe chronic heart failure.
M Packer, A J Coats, M B Fowler, H A Katus, H Krum, P Mohacsi, J L Rouleau, M Tendera, A Castaigne, E B Roecker,[...]. N Engl J Med 2001
M Packer, A J Coats, M B Fowler, H A Katus, H Krum, P Mohacsi, J L Rouleau, M Tendera, A Castaigne, E B Roecker,[...]. N Engl J Med 2001
25
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
C R Crawley, J M Foran, R K Gupta, A Z Rohatiner, K Summers, J Matthews, I N Micallef, J A Radford, S A Johnson, P W Johnson,[...]. Ann Oncol 2000
C R Crawley, J M Foran, R K Gupta, A Z Rohatiner, K Summers, J Matthews, I N Micallef, J A Radford, S A Johnson, P W Johnson,[...]. Ann Oncol 2000
12
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
William S Velasquez, Danika Lew, Thomas M Grogan, C Harris Spiridonidis, Stanley P Balcerzak, Shaker R Dakhil, Thomas P Miller, Keith S Lanier, Robert A Chapman, Richard I Fisher. J Clin Oncol 2003
William S Velasquez, Danika Lew, Thomas M Grogan, C Harris Spiridonidis, Stanley P Balcerzak, Shaker R Dakhil, Thomas P Miller, Keith S Lanier, Robert A Chapman, Richard I Fisher. J Clin Oncol 2003
12
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
P McLaughlin, F B Hagemeister, F Swan, F Cabanillas, O Pate, J E Romaguera, M A Rodriguez, J R Redman, M Keating. J Clin Oncol 1994
P McLaughlin, F B Hagemeister, F Swan, F Cabanillas, O Pate, J E Romaguera, M A Rodriguez, J R Redman, M Keating. J Clin Oncol 1994
12
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
P Solal-Céligny, P Brice, N Brousse, H Caspard, Y Bastion, C Haïoun, A Bosly, H Tilly, D Bordessoule, C Sebban,[...]. J Clin Oncol 1996
P Solal-Céligny, P Brice, N Brousse, H Caspard, Y Bastion, C Haïoun, A Bosly, H Tilly, D Bordessoule, C Sebban,[...]. J Clin Oncol 1996
12
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
P N Mainwaring, D Cunningham, W Gregory, P Hoskin, B Hancock, A J Norton, K MacLennan, P Smith, G V Hudson, D Linch. Blood 2001
P N Mainwaring, D Cunningham, W Gregory, P Hoskin, B Hancock, A J Norton, K MacLennan, P Smith, G V Hudson, D Linch. Blood 2001
12
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
P Sonneveld, M de Ridder, H van der Lelie, K Nieuwenhuis, H Schouten, A Mulder, I van Reijswoud, W Hop, B Lowenberg. J Clin Oncol 1995
P Sonneveld, M de Ridder, H van der Lelie, K Nieuwenhuis, H Schouten, A Mulder, I van Reijswoud, W Hop, B Lowenberg. J Clin Oncol 1995
12
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial.
Eva Osby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Stahl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm. Blood 2003
Eva Osby, Hans Hagberg, Stein Kvaløy, Lasse Teerenhovi, Harald Anderson, Eva Cavallin-Stahl, Harald Holte, John Myhre, Hannu Pertovaara, Magnus Björkholm. Blood 2003
12
Adrenal steroids in the treatment of malignant hematologic disease.
M J Cline. Med Clin North Am 1973
M J Cline. Med Clin North Am 1973
100
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas.
P L Zinzani, M Magagnoli, M Bendandi, F Gherlinzoni, G F Orcioni, C Cellini, V Stefoni, S A Pileri, S Tura. Ann Oncol 2000
P L Zinzani, M Magagnoli, M Bendandi, F Gherlinzoni, G F Orcioni, C Cellini, V Stefoni, S A Pileri, S Tura. Ann Oncol 2000
12
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
P McLaughlin, F B Hagemeister, J E Romaguera, A H Sarris, O Pate, A Younes, F Swan, M Keating, F Cabanillas. J Clin Oncol 1996
P McLaughlin, F B Hagemeister, J E Romaguera, A H Sarris, O Pate, A Younes, F Swan, M Keating, F Cabanillas. J Clin Oncol 1996
12
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
John J V McMurray, Jan Ostergren, Karl Swedberg, Christopher B Granger, Peter Held, Eric L Michelson, Bertil Olofsson, Salim Yusuf, Marc A Pfeffer. Lancet 2003
John J V McMurray, Jan Ostergren, Karl Swedberg, Christopher B Granger, Peter Held, Eric L Michelson, Bertil Olofsson, Salim Yusuf, Marc A Pfeffer. Lancet 2003
12
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
J Bayliss, M Norell, R Canepa-Anson, G Sutton, P Poole-Wilson. Br Heart J 1987
J Bayliss, M Norell, R Canepa-Anson, G Sutton, P Poole-Wilson. Br Heart J 1987
12
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
B Neal, S MacMahon, N Chapman. Lancet 2000
B Neal, S MacMahon, N Chapman. Lancet 2000
12
12
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
12
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Fiona Turnbull. Lancet 2003
Fiona Turnbull. Lancet 2003
12
ACE inhibitors for 'diastolic' heart failure? reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure.
J G Cleland. Eur J Heart Fail 2001
J G Cleland. Eur J Heart Fail 2001
12
Diuretic resistance predicts mortality in patients with advanced heart failure.
Gerald W Neuberg, Alan B Miller, Chris M O'Connor, Robert N Belkin, Peter E Carson, Anne B Cropp, David J Frid, Regina G Nye, Milton L Pressler, John H Wertheimer,[...]. Am Heart J 2002
Gerald W Neuberg, Alan B Miller, Chris M O'Connor, Robert N Belkin, Peter E Carson, Anne B Cropp, David J Frid, Regina G Nye, Milton L Pressler, John H Wertheimer,[...]. Am Heart J 2002
12
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.
F Braunschweig, C Linde, M J Eriksson, C Hofman-Bang, L Rydén. Eur Heart J 2002
F Braunschweig, C Linde, M J Eriksson, C Hofman-Bang, L Rydén. Eur Heart J 2002
12
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
M D Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, C Torp-Pedersen, S Ball, J Pogue, L Moyé,[...]. Lancet 2000
M D Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, C Torp-Pedersen, S Ball, J Pogue, L Moyé,[...]. Lancet 2000
12
12
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.
H A Cooper, D L Dries, C E Davis, Y L Shen, M J Domanski. Circulation 1999
H A Cooper, D L Dries, C E Davis, Y L Shen, M J Domanski. Circulation 1999
12
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Christopher B Granger, John J V McMurray, Salim Yusuf, Peter Held, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Marc A Pfeffer, Karl Swedberg. Lancet 2003
Christopher B Granger, John J V McMurray, Salim Yusuf, Peter Held, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Marc A Pfeffer, Karl Swedberg. Lancet 2003
12
Metolazone in treatment of severe refractory congestive cardiac failure.
A Kiyingi, M J Field, C C Pawsey, J Yiannikas, J R Lawrence, W J Arter. Lancet 1990
A Kiyingi, M J Field, C C Pawsey, J Yiannikas, J R Lawrence, W J Arter. Lancet 1990
12
12
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
J Malcolm O Arnold, Salim Yusuf, James Young, James Mathew, David Johnstone, Alvaro Avezum, Eva Lonn, Janice Pogue, Jackie Bosch. Circulation 2003
J Malcolm O Arnold, Salim Yusuf, James Young, James Mathew, David Johnstone, Alvaro Avezum, Eva Lonn, Janice Pogue, Jackie Bosch. Circulation 2003
12
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Marc A Pfeffer, John J V McMurray, Eric J Velazquez, Jean-Lucien Rouleau, Lars Køber, Aldo P Maggioni, Scott D Solomon, Karl Swedberg, Frans Van de Werf, Harvey White,[...]. N Engl J Med 2003
Marc A Pfeffer, John J V McMurray, Eric J Velazquez, Jean-Lucien Rouleau, Lars Køber, Aldo P Maggioni, Scott D Solomon, Karl Swedberg, Frans Van de Werf, Harvey White,[...]. N Engl J Med 2003
12
12
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Salim Yusuf, Stuart Pocock. Lancet 2003
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Salim Yusuf, Stuart Pocock. Lancet 2003
12
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
M Packer, W H Lee, N Medina, M Yushak, P D Kessler, S S Gottlieb. Am J Med 1987
M Packer, W H Lee, N Medina, M Yushak, P D Kessler, S S Gottlieb. Am J Med 1987
12
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin. N Engl J Med 2003
Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin. N Engl J Med 2003
12
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
Barry R Davis, Jeffrey A Cutler, Curt D Furberg, Jackson T Wright, Michael A Farber, James V Felicetta, John D Stokes. Ann Intern Med 2002
Barry R Davis, Jeffrey A Cutler, Curt D Furberg, Jackson T Wright, Michael A Farber, James V Felicetta, John D Stokes. Ann Intern Med 2002
12
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
W S Colucci, M Packer, M R Bristow, E M Gilbert, J N Cohn, M B Fowler, S K Krueger, R Hershberger, B F Uretsky, J A Bowers,[...]. Circulation 1996
W S Colucci, M Packer, M R Bristow, E M Gilbert, J N Cohn, M B Fowler, S K Krueger, R Hershberger, B F Uretsky, J A Bowers,[...]. Circulation 1996
12
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Stevo Julius, Sverre E Kjeldsen, Michael Weber, Hans R Brunner, Steffan Ekman, Lennart Hansson, Tsushung Hua, John Laragh, Gordon T McInnes, Lada Mitchell,[...]. Lancet 2004
Stevo Julius, Sverre E Kjeldsen, Michael Weber, Hans R Brunner, Steffan Ekman, Lennart Hansson, Tsushung Hua, John Laragh, Gordon T McInnes, Lada Mitchell,[...]. Lancet 2004
12
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
B Pitt, F Zannad, W J Remme, R Cody, A Castaigne, A Perez, J Palensky, J Wittes. N Engl J Med 1999
B Pitt, F Zannad, W J Remme, R Cody, A Castaigne, A Perez, J Palensky, J Wittes. N Engl J Med 1999
12
A rationale for the use of beta-blockers as standard treatment for heart failure.
M Metra, S Nodari, A D'Aloia, L Bontempi, E Boldi, L D Cas. Am Heart J 2000
M Metra, S Nodari, A D'Aloia, L Bontempi, E Boldi, L D Cas. Am Heart J 2000
12
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
M Packer. Circulation 1988
M Packer. Circulation 1988
12
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Kenneth Dickstein, John Kjekshus. Lancet 2002
Kenneth Dickstein, John Kjekshus. Lancet 2002
12
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
M A Pfeffer, E Braunwald, L A Moyé, L Basta, E J Brown, T E Cuddy, B R Davis, E M Geltman, S Goldman, G C Flaker. N Engl J Med 1992
M A Pfeffer, E Braunwald, L A Moyé, L Basta, E J Brown, T E Cuddy, B R Davis, E M Geltman, S Goldman, G C Flaker. N Engl J Med 1992
12
Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.
Maria Schaufelberger, Karl Swedberg, Max Köster, Måns Rosén, Annika Rosengren. Eur Heart J 2004
Maria Schaufelberger, Karl Swedberg, Max Köster, Måns Rosén, Annika Rosengren. Eur Heart J 2004
12
Obesity and the risk of heart failure.
Satish Kenchaiah, Jane C Evans, Daniel Levy, Peter W F Wilson, Emelia J Benjamin, Martin G Larson, William B Kannel, Ramachandran S Vasan. N Engl J Med 2002
Satish Kenchaiah, Jane C Evans, Daniel Levy, Peter W F Wilson, Emelia J Benjamin, Martin G Larson, William B Kannel, Ramachandran S Vasan. N Engl J Med 2002
12
Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
R J Cody, K W Franklin, J H Laragh. Am Heart J 1982
R J Cody, K W Franklin, J H Laragh. Am Heart J 1982
12
Sodium and water balance in chronic congestive heart failure.
R J Cody, A B Covit, G L Schaer, J H Laragh, J E Sealey, J Feldschuh. J Clin Invest 1986
R J Cody, A B Covit, G L Schaer, J H Laragh, J E Sealey, J Feldschuh. J Clin Invest 1986
12
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Philip A Poole-Wilson, Karl Swedberg, John G F Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J Remme,[...]. Lancet 2003
Philip A Poole-Wilson, Karl Swedberg, John G F Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J Remme,[...]. Lancet 2003
12
Trends in heart failure incidence and survival in a community-based population.
Véronique L Roger, Susan A Weston, Margaret M Redfield, Jens P Hellermann-Homan, Jill Killian, Barbara P Yawn, Steven J Jacobsen. JAMA 2004
Véronique L Roger, Susan A Weston, Margaret M Redfield, Jens P Hellermann-Homan, Jill Killian, Barbara P Yawn, Steven J Jacobsen. JAMA 2004
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.